Novo Nordisk
NVO
NVO
1,846 hedge funds and large institutions have $47.8B invested in Novo Nordisk in 2024 Q2 according to their latest regulatory filings, with 215 funds opening new positions, 754 increasing their positions, 582 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,846
Holders Change
+114
Holders Change %
+6.58%
% of All Funds
26.85%
Holding in Top 10
89
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+12.66%
% of All Funds
1.29%
New
215
Increased
754
Reduced
582
Closed
77
Calls
$1.09B
Puts
$1.13B
Net Calls
-$42.5M
Net Calls Change
+$73.9M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$371M |
| 2 |
MAM
Magellan Asset Management
Sydney,
Australia
|
+$272M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$270M |
| 4 |
Millennium Management
New York
|
+$264M |
| 5 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$227M |
